Ringpu Bio-Tech sells Hunan Zhongan stake, focuses strategy

Tianjin Ringpu Bio-Technology (SZSE:300119) announced the sale of its 48.4213% stake in subsidiary Hunan Zhongan Biopharmaceutical to Jiangxi Twin Biological Technology for CNY11.48M, to be finalized by July 31, 2025. The strategic move will allow Ringpu to focus on long-term development and key partnerships within the industry. Upon closing, Ringpu will hold a 20% stake in Zhongan, who will then partner with with Twin Biological. As a result of the sale, Zhongan will no longer be consolidated into Ringpu's financial statements.